BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (503)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 5,009.59 | 3,810.20 | 3,478.98 | 9,047.87 | 6,570.63 | |
| Net CashFlow From Operating Activities | 6,554.77 | 2,196.45 | 3,907.15 | 7,082.21 | 6,685.86 | |
| Net Cash Used In Investing Activities | -2,588.84 | -681.25 | -3,370.81 | -4,221.60 | -4,371.59 | |
| Net Cash Used From Financing Activities | -5,715.14 | -2,730.52 | -1,539.26 | -2,285.39 | -1,888.53 | |
| Foreign Exchange Gains / Losses | 363.52 | 325.65 | 147.28 | 35.45 | 422.46 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 45.52 | 119.73 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1,385.69 | -844.15 | -735.91 | 610.67 | 848.20 | |
| Cash And Cash Equivalents Begin of Year | 7,062.30 | 7,906.45 | 8,642.36 | 8,031.69 | 7,183.49 | |
| Cash And Cash Equivalents End Of Year | 5,676.61 | 7,062.30 | 7,906.45 | 8,642.36 | 8,031.69 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend